Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology

doi:10.1016/j.jfma.2020.08.026

中山醫學大學機構典藏 CSMUIR > 中山醫學大學研究成果 > 期刊論文 > Item 310902500/23466

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.csmu.edu.tw:8080/ir/handle/310902500/23466

题名:	Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology
作者:	Tsai, TF;Hsieh, TY;Chi, CC;Chou, CT;Hsieh, LF;Chen, HH;Hui, RCY;Lee, CH;Liu, CH;Liu, HC;Yeo, KJ;Chen, CH;Chen, HA;Chen, YC;Chen, YJ;Chiu, HY;Ho, JC;Huang, YH;Lai, PJ;Lee, WR;Liao, HT;Lin, SH;Tseng, JC;Wang, TS;Wu, NL;Yang, DH;Tsai, WC;Wei, JCC
关键词:	Psoriatic arthritis;Taiwan;Dermatologists;Rheumatologists
日期:	2021
上传时间:	2022-08-05T09:37:46Z (UTC)
出版者:	ELSEVIER TAIWAN
ISSN:	0929-6646
摘要:	In Taiwan, the incidence and prevalence of psoriatic arthritis (PsA) have risen significantly in recent years. Moreover, data from the Taiwan National Health Insurance Research Database (NHIRD) show that more than 85% of PsA patients are treated with just non-steroidal anti-inflammatory drugs (NSAIDs) and/or conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs). Taiwanese clinicians have also expressed concerns regarding uncertainties in the diagnosis of PsA and the delayed, interrupted, and/or tapered use of biologics, as well as differences in therapeutic preferences between and within dermatologists and rheumatologists. To address these issues, the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology jointly convened a committee of 28 clinicians from the fields of rheumatology, dermatology, orthopedics, and rehabilitation, to develop evidence-based consensus recommendations for the practical management of PsA in Taiwan. A total of six overarching principles and 13 recommendations were developed and approved, as well as a treatment algorithm with four separate tracks for axial PsA, peripheral PsA, enthesitis, and dactylitis. Psoriasis (PsO) management was not discussed here, as the Taiwanese Dermatological Association has recently published a comprehensive consensus statement on the management of PsO. Together, these recommendations provide an up-to-date, evidence-based framework for PsA care in Taiwan. Copyright (C) 2020, Formosan Medical Association. Published by Elsevier Taiwan LLC.
URI:	http://dx.doi.org/10.1016/j.jfma.2020.08.026 https://www.webofscience.com/wos/woscc/full-record/WOS:000620354100002 https://ir.csmu.edu.tw:8080/handle/310902500/23466
關聯:	JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION ,2021,v120,issue 3, P926-938
显示于类别:	[中山醫學大學研究成果] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	212	检视/开启

在CSMUIR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....